Bernard De Bruyne Selected Research

Hyperemia

1/2022	Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis.
1/2021	Duration of Hyperemia With Intracoronary Administration of Papaverine.
1/2020	Intracoronary Saline-Induced Hyperemia During Coronary Thermodilution Measurements of Absolute Coronary Blood Flow: An Animal Mechanistic Study.
10/2017	Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow Reserve.
4/2017	Saline-Induced Coronary Hyperemia: Mechanisms and Effects on Left Ventricular Function.
12/2016	The Influence of Lesion Location on the Diagnostic Accuracy of Adenosine-Free Coronary Pressure Wire Measurements.
4/2016	Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment.
9/2015	Intracoronary Adenosine: Dose-Response Relationship With Hyperemia.
7/2011	Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel.
8/2010	Effective radiation dose, time, and contrast medium to measure fractional flow reserve.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernard De Bruyne Research Topics

Disease

37	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 04/2003
31	Myocardial Infarction 01/2021 - 04/2006
30	Pathologic Constriction (Stenosis) 03/2021 - 10/2004
25	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2005
17	Hyperemia 01/2022 - 05/2002
14	Acute Coronary Syndrome 06/2022 - 05/2009
13	Coronary Stenosis (Coronary Artery Stenosis) 11/2020 - 04/2003
12	ST Elevation Myocardial Infarction 01/2021 - 05/2009
11	Thrombosis (Thrombus) 01/2021 - 01/2008
10	Stable Angina 09/2013 - 06/2008
9	Death (Near-Death Experience) 01/2021 - 10/2012
7	Hemorrhage 10/2020 - 08/2005
6	Ischemia 12/2020 - 06/2010
6	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 01/2011
5	Heart Failure 01/2021 - 03/2004
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 11/2003
5	Coronary Disease (Coronary Heart Disease) 04/2016 - 10/2007
4	Atherosclerosis 10/2016 - 09/2009
4	Rupture 12/2015 - 06/2010
3	Heart Arrest (Cardiac Arrest) 01/2021 - 12/2015
3	Non-ST Elevated Myocardial Infarction 01/2018 - 11/2011
3	Cardiomyopathies (Cardiomyopathy) 01/2018 - 12/2004
3	Unstable Angina 02/2012 - 05/2009
3	Infarction (Infarctions) 01/2007 - 08/2005
2	Diabetes Mellitus 01/2019 - 01/2014
2	Stroke (Strokes) 01/2018 - 01/2008
2	Coronary Occlusion 01/2018 - 08/2011
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 12/2015
2	Chronic Renal Insufficiency 05/2015 - 04/2014
2	Inflammation (Inflammations) 03/2013 - 08/2011
2	Chest Pain (Chest Pains) 06/2010 - 10/2005
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2008 - 06/2004
2	Pain (Aches) 10/2007 - 10/2005
2	Left Ventricular Dysfunction 06/2007 - 06/2004
1	Hemolysis 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Hypothermia 01/2021
1	Myocardial Reperfusion Injury 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Angina Pectoris 10/2015
1	Anemia 05/2015

Drug/Important Bio-Agent (IBA)

29	omega-Chloroacetophenone (Mace)IBA 03/2021 - 08/2005
16	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 05/2002
9	Clopidogrel (Plavix)FDA Link 10/2020 - 06/2008
8	Phenobarbital (Luminal)FDA Link 10/2019 - 04/2006
6	Biomarkers (Surrogate Marker)IBA 10/2015 - 01/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2005
3	Phentolamine (Z-Max)FDA LinkGeneric 12/2014 - 11/2004
3	TroponinIBA 11/2011 - 02/2008
3	Adrenergic Agents (Adrenergic Drugs)IBA 07/2007 - 11/2003
3	Dobutamine FDA LinkGeneric 06/2007 - 11/2003
2	PolymersIBA 06/2022 - 01/2020
2	Everolimus FDA Link 06/2022 - 01/2020
2	ChromiumIBA 06/2022 - 01/2020
2	titanium-nitride-oxideIBA 06/2022 - 01/2020
2	PlatinumIBA 06/2022 - 01/2020
2	CobaltIBA 06/2022 - 01/2020
2	PapaverineIBA 01/2021 - 04/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 06/2008
2	Vasodilator Agents (Vasodilators)IBA 12/2019 - 04/2016
2	CalciumIBA 10/2015 - 03/2012
2	CreatinineIBA 10/2014 - 06/2014
2	CholesterolIBA 07/2012 - 01/2010
2	Dopamine (Intropin)FDA LinkGeneric 12/2010 - 02/2006
2	Sirolimus (Rapamycin)FDA Link 01/2008 - 08/2005
2	ReninIBA 11/2006 - 10/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022
1	TitaniumIBA 06/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	IceIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	arginine methyl esterIBA 01/2020
1	Troponin T (Troponin T1)IBA 01/2020
1	Trinitrotoluene (TNT)IBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Contrast MediaIBA 10/2017
1	Complement System Proteins (Complement)IBA 07/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2017
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2016
1	MT 17IBA 04/2016
1	HDL LipoproteinsIBA 10/2015
1	Transferrin (beta 2 Transferrin)IBA 10/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2015
1	Glycoproteins (Glycoprotein)IBA 05/2015
1	bivalirudin (Angiomax)FDA Link 05/2015
1	Propranolol (Inderal)FDA LinkGeneric 12/2014

Therapy/Procedure

51	Percutaneous Coronary Intervention 01/2021 - 08/2005
26	Stents 06/2022 - 06/2002
17	Therapeutics 01/2021 - 09/2009
11	Catheters 01/2022 - 11/2006
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2020 - 06/2007
7	Drug-Eluting Stents 10/2019 - 07/2005
4	Patient Readmission 01/2021 - 10/2012
3	Transcatheter Aortic Valve Replacement 10/2020 - 01/2011
3	Cardiac Resynchronization Therapy 01/2008 - 03/2004
2	Punctures 10/2020 - 01/2020
2	Length of Stay 01/2018 - 11/2011
2	Myocardial Revascularization 07/2017 - 10/2007
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2019